IOCN Educational Events
Advance the management of immunotherapy toxicities through case conundrums
DoubleTree by Hilton Hotel, Bristol, BS1 6NJ Friday 27th March 2026
Join the IOCN Team and guests for this highly anticipated seminar at the DoubleTree by Hilton in Bristol City Centre.
This event focuses on improving strategies for identifying and managing the adverse events associated with immunotherapy treatments. Through the presentation of interesting and complex clinical cases, experts will discuss innovative approaches, share best practices, and foster collaboration among healthcare professionals. The goal is to enhance patient care by addressing the challenges posed by immunotherapy side effects, ultimately leading to better treatment outcomes. This event is ideal for Doctors (including resident doctors, SpRs and Consultants), Nurses, AHP’s and Pharmacists.
The seminar will cover a range of topics including:
- Baseline Screening
- Practical recognition of toxicity
- Identifying common patterns of presentation
- Initial monitoring and management of different toxicities
- Steroid management and considerations
- Escalation of patient care
- Fatigue
- Introduction to additional immunosupression
- Approach to escalating beyond steroids
Seminar Highlights:
- Expert-led sessions
- Cutting-edge topics
- Interactive learning
- Networking opportunities
- CPD Accreditation
IOCN Case Report Abstract Submission
Have you encountered a fascinating case involving immune-related toxicity in immuno-oncology?
We invite you to showcase your experiences at our upcoming conference! Submit your abstracts to join leading experts and showcase real-world experiences and solutions in managing immune-related adverse events (irAEs). Selected authors will have the unique opportunity to present their work as posters, gaining exposure for their valuable insights and contributing to advances in the field.
✨ What We’re Looking For:
-
Case studies detailing unique or complex irAEs
-
Best practices in toxicity management for immune checkpoint inhibitors
-
Multidisciplinary approaches to IO toxicity care
This is your chance to share your expertise and connect with peers passionate about advancing immuno-oncology care!
✨Example Topics for Submission:
- Management of Multiple irAEs in Metastatic Cancer Patients: Share cases where overlapping toxicities required innovative or multidisciplinary approaches.
- Checkpoint Inhibitor-Related Complications: Insights into severe or unusual adverse events, such as myocarditis, pneumonitis, and colitis, and strategies for managing them.
- Balancing Efficacy and Safety: Case studies that demonstrate the intricate balance between achieving therapeutic benefits and managing toxicity.
- Toxicities related to Novel Immunotherapeutics
Abstract Word Limit: 200 Words
Deadline: 1st February 2026 - 11:59pm
Adverse events should be reported. Please ensure that the details of your case report have been reported via the yellow card scheme. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.